Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Med Care. 2021 Jun 1;59(6):477–486. doi: 10.1097/MLR.0000000000001521

Table 3.

Health status and service utilization in fiscal years (FY) 2011 and 2013 by utilization of education, case management, and advanced practice pharmacy (ECP) services in FY2012. Bivariate associations.a

All adults with diabetes Adults with diabetes absent CVD Adults with diabetes and CVD
ECP non-users ECP users ECP non-users ECP users ECP non-users ECP users
All adults with diabetes 16,855 11,723 12,733 8,044 4,122 3,679
Clinical Measures
High SBP ≥ 140 mmHgb
 FY 2011 23.6% 22.6% 21.8% 20.4% 29.0% 27.5%
 FY 2013 25.9% 23.8% ** 24.4% 21.5% *** 30.7% 28.7%
 Difference 2.4% 1.2% 2.6% 1.2% 1.7% 1.2%
High hemoglobin A1c ≥ 8%b
 FY 2011 42.5% 44.5% * 43.2% 45.4% * 40.4% 42.5%
 FY 2013 46.3% 46.7% 47.2% 47.5% 43.8% 45.0%
 Difference 3.9% 2.2% * 4.0% 2.1% * 3.4% 2.4%
High LDL cholesterol ≥ 100 mg/dLb
 FY 2011 44.1% 38.5% *** 46.9% 42.0% *** 36.2% 31.5% **
 FY 2013 38.8% 34.0% *** 41.3% 37.6% *** 31.8% 26.7% **
 Difference −5.3% −4.6% −5.6% −4.5% −4.3% −4.7%
Onset of CVD 2013 7.3% 9.1% ***
Onset of ESRD 2013 0.5% 0.4% 0.2% 0.1% 1.5% 1.1%
Hospital service use
Average number of I/T ED visits
 FY 2011 0.79 0.78 0.69 0.62 ** 1.10 1.12
 FY 2013 0.82 0.75 *** 0.75 0.64 *** 1.03 0.98
 Difference 0.03 −0.03 ** 0.07 0.02 * −0.06 −0.14
Percent with 1 or more hospitalizations
 FY 2011 8.8% 10.3% *** 5.5% 5.7% 19.9% 21.2%
 FY 2013 8.6% 8.9% 6.8% 6.5% 14.8% 14.5%
 Difference −0.2% −1.4% ** 1.3% 0.8% −5.2% −6.7%
Average number of inpatient days
 FY 2011 0.49 0.61 ** 0.23 0.25 1.32 1.46
 FY 2013 0.62 0.63 0.41 0.36 1.28 1.27
 Difference 0.13 0.02 0.18 0.11 0.04 −0.19
Percent with 1 or more I/T potentially preventable hospitalizations
 FY 2011 2.1% 2.6% ** 1.1% 1.3% 5.0% 5.5%
 FY 2013 2.3% 2.3% 1.5% 1.4% 4.7% 4.2%
 Difference 0.2% −0.4% * 0.4% 0.1% −0.4% −1.3%

FY: fiscal year; CVD: cardiovascular disease; SBP: systolic blood pressure; LDL: low-density lipoprotein; ESRD: end-stage renal disease; I/T: Indian Health Service and Tribal

*

p < 0.05;

**

p < 0.01;

***

p < 0.001

a

Associations between values for ECP users and non-users during FY2011, FY2013, and the difference between the 2 years.

b

These clinical measures were assessed for adults in the study population who had both FY2011 and FY2013 data.